Picture of Kalaris Therapeutics logo

KLRS — Kalaris Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Gilead Sciences Inc reports 14.8% passive stake in Allovir

Aug 8 (Reuters) - 
    * GILEAD SCIENCES INC REPORTS 14.8% PASSIVE STAKE IN ALLOVIR
INC
AS OF JULY 28 - SEC FILING

Further company coverage:  ALVR.O 

 (Reporting by Priyamvada C)
 ((Priyamvada.C@thomsonreuters.com;))

Recent news on Kalaris Therapeutics

See all news